Myocardial T1: The rise of a novel biomarker continues

JACC: Cardiovascular Imaging

Volumn 8, Issue 1, 2015, Pages 47-49

  Friedrich, Matthias G ^a,b,c  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b MONTREAL HEART INSTITUTE   (Canada)

^c UNIVERSITY OF CALGARY   (Canada)

Author keywords

Cardiac magnetic resonance; Myocardial inflammation; Myocarditis; Native T1

Indexed keywords

BIOLOGICAL MARKER; GADOLINIUM;

ACUTE HEART INFARCTION; CARDIAC IMAGING; CARDIOVASCULAR MAGNETIC RESONANCE; CONTRAST ENHANCEMENT; HEART; HUMAN; MYOCARDIAL T1 MAPPING; MYOCARDITIS; PRIORITY JOURNAL; REVIEW; ALGORITHM; NUCLEAR MAGNETIC RESONANCE IMAGING;

ALGORITHMS; HUMANS; MAGNETIC RESONANCE IMAGING; MYOCARDITIS;

EID: 84922586881     PISSN: 1936878X     EISSN: 18767591     Source Type: Journal    
DOI: 10.1016/j.jcmg.2014.10.002     Document Type: Editorial

References (13)

1. Henry Ford. Available at: http://www.quotes.net/quote/6034. Accessed November 7, 2014.
2. Oxford Dictionary. Available at: http://www.oxforddictionaries.com/definition/english/biomarker. Accessed November 7, 2014.
3. Messroghli DR, Niendorf T, Schulz-Menger J, Dietz R, Friedrich MG. T1 mapping in patients with acute myocardial infarction. J Cardiovasc Magn Reson 2003;5:353-9.
4. Hinojar R, Foote L, Arroyo Ucar E, et al. Native T1 in discrimination of acute and convalescent stages in patients with clinical diagnosis of myocarditis: a proposed diagnostic algorithm using CMR. J Am Coll Cardiol Img 2015;8:37-46.
5. Ferreira VM, Piechnik SK, Dall'armellina E, et al. Native T1-mapping detects the location, extent and patterns of acute myocarditis without the need for gadolinium contrast agents. J Cardiovasc Magn Reson 2014;16:36.
6. Dass S, Suttie JJ, Piechnik SK, et al. Myocardial tissue characterization using magnetic resonance noncontrast t1 mapping in hypertrophic and dilated cardiomyopathy. Circ Cardiovasc Imaging 2012;5:726-33.
7. Puntmann VO, D'Cruz D, Smith Z, et al. Native myocardial T1 mapping by cardiovascular magnetic resonance imaging in subclinical cardiomyopathy in patients with systemic lupus erythematosus. Circ Cardiovasc Imaging 2013;6: 295-301.
8. Fontana M, Banypersad SM, Treibel TA, et al. Native T1 mapping in transthyretin amyloidosis. J Am Coll Cardiol Img 2014;7:157-65.
9. h-Ici DO, Jeuthe S, Al-Wakeel N, et al. T1 mapping in ischaemic heart disease. Eur Heart J Cardiovasc Imaging 2014;15:597-602.
10. Moon JC, Messroghli DR, Kellman P, et al. Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement. J Cardiovasc Magn Reson 2013;15:92.
11. Piechnik SK, Ferreira VM, Dall'armellina E, et al. Shortened Modified Look-Locker Inversion recovery (ShMOLLI) for clinical myocardial T1-mapping at 1.5 and 3 T within a 9 heartbeat breathhold. J Cardiovasc Magn Reson 2010;12:69.
12. Knobelsdorff-Brenkenhoff von F, Prothmann M, Dieringer MA, et al. Myocardial T1 and T2 mapping at 3 T: reference values, influencing factors and implications. J Cardiovasc Magn Reson 2013;15:53.
13. Kellman P, Hansen MS. T1-mapping in the heart: accuracy and precision. J Cardiovasc Magn Reson 2014;16:1-20.